CLASS II ONGOING Drug recall · Reported 5 Nov 2025 · FDA Enforcement Report

Hadlima (adalimumab-bwwd) injection recalled by Samsung Bioepis Co

Samsung Bioepis is recalling Hadlima (adalimumab-bwwd) injection, 40mg/-dose Prefilled Syringes per, distributed in New Jersey. The recall was initiated on 10 Oct 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: F2505017, Expiry: 24-Jan-2027
Quantity recalled5,518 packs (11,036 Syringes) 2 syringes/carton)

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0099-2026
FDA event ID
97710
Recalling firm
Samsung Bioepis, Yeonsu, N/A
Classification
Class II
Status
Ongoing
Recall initiated
10 Oct 2025
FDA classified
24 Oct 2025
Reported
5 Nov 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

10 Oct 2025Recall initiated by company
24 Oct 2025Classified by FDA+14 days
5 Nov 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

HADLIMA (adalimumab-bwwd) injection, 40mg/0.8 mL, 2 Single-dose Prefilled Syringes per carton, Rx only, Manufactured for: Organon LLC, a subsidiary of ORGANON & Co, Jersey City, NJ 07302, Manufactured by: SAMSUN BIOEPIS Co., Ltd, Incheon, Republic of Korea, NDC 78206-183-01.

Where it was distributed

Distributed only to one warehouse in NJ. with no further distribution

New Jersey

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility.

Which lots are affected?

Lot: F2505017, Expiry: 24-Jan-2027

Where was it sold?

Distributed only to one warehouse in NJ. with no further distribution

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.